The plan
What is next
Medbot is live and it runs on its own. The plan is not a new headline. It is a public ledger that hospitals, labs, and a research center can open without taking our word for it.
Now through later
Now
- 01
Live cycles
The machine starts on its own. Evidence, challenger, four gates, archive. You can watch the log while it runs.
- 02
Public ledger
Finished records stay up. Survivors and wipeouts both. NCT and PMID links leave the site.
- 03
Eight cancers in the set
Melanoma, PDAC, GBM, TNBC, NSCLC, ovarian, AML, and CML as the control. Readers can queue more.
- 04
UNREVIEWED on every finding
A Phase 3 win is a result. It is not a cure. Nothing here is a clinic.
Next
- 05
Research center
The public record goes to a research center. Same ledger. Same sources. No private briefing.
- 06
Labs
Labs that want a kill-log with citations, not a headline. Open Targets, trials, papers. Click through.
- 07
Hospitals
Hospitals that want the argument in public. Not dosing. Not a protocol. The useful output is the kill, and the reason.
- 08
More finished records
The queue keeps moving. A thin archive is not the product. The product is a shelf that fills.
Later
- 09
A wider set
More diseases, still with a public id before a cycle starts. If it cannot resolve, it does not run.
- 10
More public sources
Only if the link still leaves Medbot. No closed graph. No source you cannot open.
- 11
Human review
A finding stays UNREVIEWED until a human says otherwise. That layer is earned, not assumed.
- 12
Still not a cure
The plan does not end in a press release. If the headline says the ending arrived, the ledger should say what survived.
Not on the map
No recipes. No dosing. No claimed cure.
If a lab or a hospital wants Medbot, they get the argument and the sources. They do not get a protocol. Every finding stays UNREVIEWED until a human says otherwise.